Allo-Aca treatment reduced the numbers of neutrophils in BALF (Fig. 3b), peribronchial inflammation (H&E) (Fig. 3c), goblet cell hyperplasia (PAS) (Fig. 3d), and the levels of Th1/17-related inflammatory cytokines (Fig. 3e) in LPS/OVA + OVA-treated female obese mice, indicating that Allo-Aca inhibited the obese-related neutrophilic airway inflammation. This evidence concerns the gene NELFCD and inflammation.